Insight Molecular Diagnostics's total assets for Q3 2025 were $43.94M, a decrease of -13.03% from the previous quarter. IMDX total liabilities were $53.13M for the fiscal quarter, a 7.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.